Created at	Source	Raw Value	Validated value
July 4, 2024, 8 a.m.	usa	Clinical Activity (Response)(Phase 2);Maximum Tolerated Dose (MTD) (Phase 1)	Clinical Activity (Response)(Phase 2);Maximum Tolerated Dose (MTD) (Phase 1)
Oct. 26, 2020, 11:31 p.m.	usa	Incidence of toxicity, graded according to the NCI CTCAE version 5;Maximum tolerated dose (MTD) (Phase 1);Clinical activity (Response)(Phase 2)	Incidence of toxicity, graded according to the NCI CTCAE version 5;Maximum tolerated dose (MTD) (Phase 1);Clinical activity (Response)(Phase 2)